Role of adenosine A2b receptor overexpression in tumor progression

Life Sci. 2016 Dec 1:166:92-99. doi: 10.1016/j.lfs.2016.10.008. Epub 2016 Oct 8.

Abstract

The adenosine A2b receptor is a G-protein coupled receptor. Its activation occurs with high extracellular adenosine concentration, for example in inflammation or hypoxia. These conditions are generated in the tumor environment. Studies show that A2b receptor is overexpressed in various tumor lines and biopsies from patients with different cancers. This suggests that A2b receptor can be used by tumor cells to promote progression. Thus A2b participates in different events, such as angiogenesis and metastasis, besides exerting immunomodulatory effects that protect tumor cells. Therefore, adenosine A2b receptor appears as an interesting therapeutic target for cancer treatment.

Keywords: A2b receptor; Adenosine; Cancer; Immunosuppressive; Tumor.

Publication types

  • Review

MeSH terms

  • Adenosine / analysis
  • Adenosine / genetics
  • Adenosine / immunology
  • Adenosine A2 Receptor Antagonists / pharmacology
  • Adenosine A2 Receptor Antagonists / therapeutic use
  • Animals
  • Disease Progression
  • Gene Expression Regulation, Neoplastic* / drug effects
  • Humans
  • Immune Tolerance / drug effects
  • Molecular Targeted Therapy / methods
  • Neoplasms / drug therapy
  • Neoplasms / genetics*
  • Neoplasms / immunology
  • Neoplasms / pathology*
  • Receptor, Adenosine A2B / analysis
  • Receptor, Adenosine A2B / genetics*
  • Receptor, Adenosine A2B / immunology
  • Tumor Microenvironment / drug effects
  • Up-Regulation* / drug effects

Substances

  • Adenosine A2 Receptor Antagonists
  • Receptor, Adenosine A2B
  • Adenosine